No Data
No Data
Institutional Owners May Ignore Pyxis Oncology, Inc.'s (NASDAQ:PYXS) Recent US$25m Market Cap Decline as Longer-term Profits Stay in the Green
Express News | Pyxis Oncology Expands Board of Directors With Appointment of Michael a. Metzger
Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Hims & Hers Health (HIMS) and Cytokinetics (CYTK)
Pyxis Oncology | 10-Q: Quarterly report
Pyxis Oncology 1Q Research and Development Expenses $13.0M >PYXS
Pyxis Oncology 1Q Research and Development Expenses $13.0M >PYXS
Pyxis Oncology 1Q Loss/Shr 6c >PYXS
Pyxis Oncology 1Q Loss/Shr 6c >PYXS